4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents

Biomedicine and Pharmacotherapy

Volumn 65, Issue 4, 2011, Pages 313-316

  De Souza, Nicolli Bellotti ^a   Carmo, Arturene M L ^a   Lagatta, Davi C ^a   Alves, Márcio José Martins ^a   Fontes, Ana Paula Soares ^a   Coimbra, Elaine Soares ^a   Da Silva, Adilson David ^a   Abramo, Clarice ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Antimalarial activity; Plasmodium berghei; Platinum (II) complexes; Quinoline

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; IN VIVO STUDY; MOUSE; NONHUMAN; PARASITE CONTROL; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; MACROPHAGES, PERITONEAL; MALARIA; MICE; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; PLASMODIUM BERGHEI;

EID: 79960399853     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.03.003     Document Type: Article

References (26)

1. Kano F.W.S., Kino H., Ishih A. Exp Parasitol 2009, 121:376-380.
2. Haas S.E., Bettoni C.C., Oliveira L.K., Guterres S.S., Costa T.D. Int J Antimicrob Agents 2009, 34:156-161.
3. Madapa S., Tusi Z., Sridhar D., Kumar A., Siddiqi M.I., Srivastava K., et al. Bioorg Med Chem 2009, 17:203-221.
4. Pasternak N.D., Dzikowski R. Int J Biochem Cell Biol 2009, 41:1463-1466.
5. Witkowski B., Berry A., Benoit-Vical F. Drug Resist Updat 2009, 12:42-50.
6. World Health Organization, 2009. Malaria Fact Sheet, no 94 (). http://www.who.int/mediacentre/factsheets/fs094/en/index.html.
7. Kigondu E.V.M., Rukunga G.M., Keriko J.M., Tonui W.K., Gathirwa J.W., Kirira P.G., et al. J Ethnopharmacol 2009, 123:504-509.
8. Fidock D.A., Eastman R.T., Ward S.A., Meshnick S.R. Trends Parasitol 2008, 24:537-544.
9. Rukunga G.M., Gathirwa J.W., Omara S.A., Muregi F.W., Muthaura C.N., Kirira P.G., et al. J Ethnopharmacol 2009, 121:282-285.
10. Casagrande M., Basilico N., Parapini S., Romeo S., Taramelli D., Sparatore A. Bioorg Med Chem 2008, 16:6813-6823.
11. Barazarte A., Lobo G., Gamboa N., Rodrigues J.R., Capparelli M.V., Álvarez-Larena A., et al. Eur J Med Chem 2009, 44:1303-1310.
12. Mishra A., Srivastava K., Tripathi R., Puri S.K., Batra S. Eur J Med Chem 2009, 44:4404-4412.
13. Chonga C.R., Sullivan D.J. Biochem Pharm 2003, 66:2201-2212.
14. Watkins E.R., Meshnick S.R. Semin Pediatr Infect Dis 2000, 11:202-212.
15. Foley M., Tilley L. Pharmacol Ther 1998, 79:55-87.
16. Kouznetsov V., Meléndez-Gómez C. UNIVERSITAS SCIENTIARUM. Revista de la Facultad de Ciencias 2005, 10:5-18.
17. Hawley S.R., Bray P.G., Mungthin M., Atkinson J.D., O'Neill P.M., Ward S.A. Antimicrob Agents Chemother 1998, 42:682-686.
18. Vashist U., Carvalhaes R., D'agosto M., Da Silva A.D. Chem Biol Drug Des 2009, 74:434-437.
19. Keith C.T., Borisy A.A., Stockwell B.R. Nat Rev Drug Discov 2005, 4:71-78.
20. Dorn A., Vippagunta S.R., Matile H., Jaquet C., Vennerstrom J.L., Ridley R.G. Biochem Pharmacol 1998, 55:727-736.
21. Acharya B.N., Saraswat D., Tiwari M., Shrivastava A.K., Ghorpade R., Bapna S., et al. Eur J Med Chem 2010, 45:430-438.
22. Sullivan D.J. Int J Parasitol 2002, 32:1645-1653.
23. Coimbra E.S., De Almeida M.V., Junior C.O.R., Taveira A.F., da Costa C.F., de Almeida A.C., et al. Synthesis and antileishmanial activity of lipidic amino alcohols. Chem Biol Drug Des 2010, 75:233-235.
24. Corrales R.N.R., Pinheiro L.S., Coimbra E.S., Da Silva A.D., Le Hyaric M. Synthesis and antileishmanial activity of lipophilic aromatic aminoalcohols. Sci World J 2010, 10:1067-1072.
25. Peters W. Exp Parasitol 1965, 17:80-89.
26. Carvalho L.H., Brandão M.G.L., Santos-Filho D., Lopes J.L.C., Kretlli A.U. Braz J Med Biol Res 1991, 24:1113-1123.